HOME >> MEDICINE >> NEWS
Now is a pivotal point in history to abolish state execution

This is a pivotal point in history for countries to consider evidence that demonstrates the barbarity of lethal injection and abolish state execution, states an editorial in this week's issue of The Lancet.

Last year The Lancet published a paper, which found that despite a theoretically lethal dose of the barbiturate thiopental, given before the injection of pancuronium to paralyse breathing muscles and potassium chloride to stop the heart, 21 of 49 executed US inmates had postmortem thiopental concentrations consistent with consciousness (See Lancet 2005; 365: 141214). Now, a Californian judge--Judge Jeremy Fogel--has ruled that the state must either rely solely on thiopental, or else have a qualified individual confirm unconsciousness before the injection of pancuronium and potassium chloride, in order to avoid excessive pain. As a result, Californian officials have had to postpone the execution of a convicted murderer by lethal injection after they were unable to find medical personnel willing to participate. Involvement in executions contradicts the principles of many professional organisations in the US, including the American Medical Association.

The Lancet comments: "This is a pivotal point in history. A moment when individuals, like Judge Fogel, and the anaesthetists who refused to participate, have given voice to their conscience. They have articulated the concerns of an increasing number of Americans, whose support for capital punishment has dropped from 80% to 64% in the past decade. It is a voice to be heeded. As Judge Fogel noted, the Eighth Amendment has been interpreted as prohibiting punishments that are 'incompatible with the evolving standards of decency that mark the progress of a maturing society'. In 2004, China, Iran, Vietnam, and the USA accounted for 97% of the world's executions. From which of these countries will a mature society take the lead, and abolish the atrocity of state execution?"


'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
2-Mar-2006


Page: 1

Related medicine news :

1. Asthmatx completes enrollment in pivotal study of bronchial thermoplasty
2. Approval to start US BTT pivotal trial
3. Bayer and Onyx announce pivotal Nexavar kidney cancer study published in NEJM
4. New data show CAS in clinical practice has comparable MAE rate with pivotal sapphire trial
5. Orqis Medical receives unconditional FDA approval for pivotal trial of percutaneous CHF therapy
6. Metabolic syndrome points to heart health
7. Gene variations point to why lung cancer drugs work better in Japanese vs. US patients
8. Mouse model points to possible new strategy for treating rare muscle disease, kidney disorders
9. System to pinpoint airline passengers who contaminate cabins
10. Novel anti-oxidant and anti-inflammatory agent shows effectiveness on key endpoints in trial
11. Jefferson scientists find that drug-eluting stents are disappointing in bypass grafts -- sometimes

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Now pivotal point history abolish state execution

(Date:11/22/2014)... 22, 2014 Setria® Glutathione is ... approved it for use “as a therapeutically active ... within the Therapeutic Goods (Listing) Notice 2014 (No. ... Hakko’s Setria® Glutathione will be exclusivity distributed in ... sources and imports fine chemicals to Australian manufacturers. ...
(Date:11/22/2014)... PITTSBURGH, PA (PRWEB) November 22, 2014 ... about the pain caused by the machine," said an ... injury, she had to go back a second time ... my invention idea." , She developed the patent-pending MAMO ... for breast cancer. The design saves the patient from ...
(Date:11/22/2014)... Lipitor lawsuits ( http://www.lipitorlawsuitcenter.com/ ) that ... developed Type 2 diabetes due to its use continue ... underway in U.S. District Court, District of South Carolina, ... litigation will convene its next Status Conference on December ... Counsel for Plaintiffs and Defendants to meet and confer, ...
(Date:11/22/2014)... November 22, 2014 The Sports Conflict ... Roy Baroff to its team of conflict resolution professionals. ... player, coach, and referee. He has over 30 years experience ... beyond. , “I'm very excited to connect with SCI and ... related interests to a program with a complete sports focus,” ...
(Date:11/22/2014)... (PRWEB) November 22, 2014 Wright & ... AndroGel side-effects lawsuits have been scheduled between October ... Northern District of Illinois. U.S. District Judge Matthew F. ... a Case Management Order (CMO) on November 6, 2014 ... for attorneys to submit documents and other activities in ...
Breaking Medicine News(10 mins):Health News:Setria® Glutathione Now Available in Australia 2Health News:Setria® Glutathione Now Available in Australia 3Health News:Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP Reports 2Health News:Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP Reports 3Health News:SCI Announces New Team Member Roy Baroff 2Health News:SCI Announces New Team Member Roy Baroff 3Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 2Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 3Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 4
(Date:11/22/2014)... 2014 Many power shifts are occurring ... of patients in the biopharmaceutical market is impacting ... than ever, understanding how to effectively acquire, convert, ... essential. According to recent research ... spent about two-thirds of their patient-focused dollars on ...
(Date:11/21/2014)... Nov. 21, 2014 In September 2014, the ... carried out a new product development plan that started ... "limited edition" lab coat , aptly named "Vera ... surgery in the world. The new women,s designer lab ... with a sleek envelope collar, vertical princess and high ...
(Date:11/21/2014)... , Nov. 21, 2014  PTC Therapeutics, Inc. (NASDAQ: ... 2014 Legend of Technology Award for Vision, Innovation, and Leadership ... Chief Executive Officer. This award recognizes an individual who has ... New Jersey for several decades. ... Award," stated Stuart Peltz , Ph.D., CEO of PTC ...
Breaking Medicine Technology:New Report Details Importance of Adopting a "Patient Journey" Framework in Marketing 2Medelita Introduces Medical Industry's First Limited Edition Women's Designer Lab Coat 2PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award 2PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award 3
Cached News: